Pharma channel feed

Ar­genx de­buts first DTC for myas­the­nia gravis med Vyv­gart even as MG com­mu­ni­ty ef­fort con­tin­ues

4 years ago
Marketing

Covid vac­cine mak­ers Pfiz­er, J&J notch high brand marks amid over­all still-strong phar­ma in­dus­try rep: Har­ris Poll

4 years ago
Marketing

A $3B+ peak sales win? Pfiz­er thinks so, as FDA of­fers a tardy green light to its JAK1 drug abroc­i­tinib

4 years ago
FDA+

Ex­clu­sive: Bio­gen lead­ers warn sales teams: On­ly 2,000 pa­tients might ac­cess Aduhelm over the next sev­er­al years

4 years ago

Twit­ter aims to bring med­ical con­fer­ences — and ad spon­sors — from ‘in­side 4 walls and 3 days’ to dig­i­tal fu­ture

4 years ago
Marketing

Bio­gen vows to fight CM­S' draft cov­er­age de­ci­sion for Aduhelm be­fore April fi­nal­iza­tion

4 years ago

Ac­tress Jen­nifer Anis­ton stars in Idor­si­a's de­but cam­paign to raise aware­ness for in­som­nia

4 years ago
Marketing

‘Skin­ny la­bels’ on gener­ics can save pa­tients mon­ey, re­search shows, but re­cent court de­ci­sions cloud fu­ture

4 years ago

Dai­ichi Sankyo shuts down Plexxikon sub­sidiary to stream­line En­her­tu, ADC de­vel­op­ment

4 years ago
People
R&D

Ex­clu­sive: Bio­gen pres­i­dent fears CMS will fi­nal­ize re­stric­tive cov­er­age de­ci­sion for Aduhelm, preps plans to flood NCD with com­ments

4 years ago
R&D

Reel­ing from FDA re­jec­tion, Be­yond­Spring ax­es 35% of US staffers in hopes of I/O come­back

4 years ago
People
China

'Seeds of change' sprout in­to high­er pro­ject­ed re­turn on in­vest­ments for the bio­phar­ma in­dus­try, ac­cord­ing to De­loitte

4 years ago

Pfiz­er lays off hun­dreds of US sales rep as few­er in-per­son meet­ings ex­pect­ed to re­main per­ma­nent

4 years ago
Marketing

CMS to re­strict cov­er­age of Bio­gen's con­tro­ver­sial Alzheimer's drug to on­ly clin­i­cal tri­als

4 years ago

Mar­ket­ingRx roundup: Neu­ro­crine amps tar­dive dysk­i­ne­sia cam­paign; FDA study finds an­i­ma­tion has lit­tle ef­fect in DTC ads

4 years ago
Marketing

En­do piv­ots from NFL star John El­way to re­al pa­tients in Dupuytren’s con­trac­ture aware­ness ads

4 years ago
Marketing

Da­ta an­a­lyt­ics looms large as Pharm­Stars dig­i­tal health ac­cel­er­a­tor wraps first 'Phar­mU' start­up class

4 years ago
Marketing

7 block­busters: An­a­lysts spot­light 2022’s crop of drugs most like­ly to win top mar­ket­ing sta­tus — 2 drugs dom­i­nate

4 years ago
R&D

Phar­ma brands spent $3.9B on TV ads in 2021, led by Sanofi, Re­gen­eron’s Dupix­ent and No­vo Nordisk’s Ry­bel­sus

4 years ago
Marketing

Health takes cen­ter stage at an­nu­al CES tech bash with ad­vanced wear­ables, tele­health deals and lat­est in Covid test­ing

4 years ago
Marketing

No­var­tis snaps up the rights to a Covid-19 an­tivi­ral af­ter see­ing mid-stage re­sults. So where are the da­ta?

4 years ago
Coronavirus

Make or break for Bio­gen: How the na­tion­al cov­er­age de­ci­sion for amy­loid-tar­get­ed Alzheimer’s drugs will shake out

4 years ago

FDA ap­proves po­ten­tial block­buster in­som­nia drug, a first for Swiss biotech Idor­sia

4 years ago
FDA+

Dig­i­tal doc­tors’ mes­sage to phar­ma mar­keters: Lay off email del­uge and ramp up cus­tom con­tent

4 years ago
Marketing
First page Previous page 228229230231232233234 Next page Last page
A service from the Financial Times